Vitatex holds exclusive U.S. licenses for broad patent applications based on CAM-related technologies (“Methods and compositions for isolating metastatic cancer cells”, “Cell separation matrix” and “Blood test prototypes and methods”) from the State University of New York at Stony Brook. These patents have also evolved into several patent applications and accompanying international PCT applications for China, Japan, Canada, Australia and the European Union. In addition, Vitatex holds exclusive U.S. licenses for two patent applications on “Compositions and Methods for Inhibition of tumor invasion and angiogenesis”.